Evidence map›Paper›PMID 39852071›Full record

ArticleBiosensors2025

Evaluating Normalization Methods for Robust Spectral Performance Assessments of Hyperspectral Imaging Cameras.

Siavash Mazdeyasna, Mohammed Shahriar Arefin, Andrew Fales, Silas J Leavesley, T Joshua Pfefer, Quanzeng Wang

Abstract read
In one paragraph

Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Siavash MazdeyasnaCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0001-5683-9866
Mohammed Shahriar ArefinCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0002-2248-7687
Andrew FalesCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0001-7232-8636
Silas J LeavesleyChemical and Biomolecular Engineering, University of South Alabama, Mobile, AL 36688, USA.ORCID 0000-0002-2684-9534
T Joshua PfeferCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.
Quanzeng WangCenter for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.ORCID 0000-0002-0557-7058

Funding

U.S. Food and Drug Administration 2023DBP1099
6 · The paper itself

Abstract

Hyperspectral imaging (HSI) technology, which offers both spatial and spectral information, holds significant potential for enhancing diagnostic performance during endoscopy and other medical procedures. However, quantitative evaluation of HSI cameras is challenging due to various influencing factors (e.g., light sources, working distance, and illumination angle) that can alter the reflectance spectra of the same target as these factors vary. Towards robust, universal test methods, we evaluated several data normalization methods aimed at minimizing the impact of these factors. Using a high-resolution HSI camera, we measured the reflectance spectra of diffuse reflectance targets illuminated by two different light sources. These spectra, along with the reference spectra from the target manufacturer, were normalized with nine different methods (e.g., area under the curve, standard normal variate, and centering power methods), followed by a uniform scaling step. We then compared the measured spectra to the reference to evaluate the capability of each normalization method in ensuring a consistent, standardized performance evaluation. Our results demonstrate that normalization can mitigate the impact of some factors during HSI camera evaluation, with performance varying across methods. Generally, noisy spectra pose challenges for normalization methods that rely on limited reflectance values, while methods based on reflectance values across the entire spectrum (such as standard normal variate) perform better. The findings also suggest that absolute reflectance spectral measurements may be less effective for clinical diagnostics, whereas normalized spectral measurements are likely more appropriate. These findings provide a foundation for standardized performance testing of HSI-based medical devices, promoting the adoption of high-quality HSI technology for critical applications such as early cancer detection.

Indexed as

Hyperspectral ImagingHumansbiascenteringcorrelation coefficienthyperspectral endoscopylinear transformationmedical hyperspectral imagingnonlinear transformationnormalizationreflectance spectrumroot mean square errorscaling

Identifiers

PMID39852071
PMCPMC11763101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.